拓普集團(601689.SH):擬發行可轉債募資不超25億元 用於年產330萬套輕量化底盤系統建設項目等
格隆匯11月19日丨拓普集團(601689.SH)公佈公開發行可轉換公司債券預案,本次擬發行可轉換公司債券總規模不超過人民幣25億元(含25億元),具體發行規模提請公司股東大會授權董事會在上述額度範圍內確定。
本次發行的可轉換公司債券每張面值為人民幣100元,按面值發行。本次發行的可轉換公司債券的期限為自發行之日起六年。
本次公開發行可轉換公司債券募集資金總額不超過25億元(含25億元),扣除發行費用後,將全部投資於年產150萬套輕量化底盤系統建設項目(擬投7.21億元)和年產330萬套輕量化底盤系統建設項目(擬投17.79億元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.